{"id":1339,"date":"2017-01-27T00:01:21","date_gmt":"2017-01-27T00:01:21","guid":{"rendered":"http:\/\/live.hepatology.ca\/?page_id=1339"},"modified":"2025-01-27T18:21:50","modified_gmt":"2025-01-27T18:21:50","slug":"special-interest-groups","status":"publish","type":"page","link":"https:\/\/hepatology.ca\/fr\/research\/special-interest-groups\/","title":{"rendered":"Groupes d&#039;int\u00e9r\u00eats sp\u00e9ciaux"},"content":{"rendered":"<div data-elementor-type=\"wp-page\" data-elementor-id=\"1339\" class=\"elementor elementor-1339\">\n\t\t\t\t<div class=\"elementor-element elementor-element-3d62a99f e-flex e-con-boxed e-con e-parent\" data-id=\"3d62a99f\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-13c6d615 elementor-widget elementor-widget-text-editor\" data-id=\"13c6d615\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Politique et avantages des groupes d&#039;int\u00e9r\u00eats sp\u00e9ciaux<\/strong><\/p>\n<p><span style=\"background-color: var(--ast-global-color-5); color: var( --e-global-color-text ); font-family: var( --e-global-typography-text-font-family ), Sans-serif; font-style: inherit; font-weight: inherit; text-align: var(--text-align);\">L\u2019ACSV s\u2019engage \u00e0 soutenir la communaut\u00e9 de l\u2019h\u00e9patologie dans l\u2019avancement de la recherche et des r\u00e9seaux pour approfondir les connaissances et les options de traitement des maladies du foie.<\/span><\/p>\n<p>Dans cet esprit, nous apportons notre soutien officiel aux groupes d\u2019int\u00e9r\u00eat sp\u00e9ciaux (GIS), afin de promouvoir la collaboration de scientifiques et de professionnels de la sant\u00e9 issus de diverses disciplines qui partagent des int\u00e9r\u00eats sp\u00e9cialis\u00e9s communs dans le domaine de l\u2019h\u00e9patologie.<\/p>\n<p>Nos groupes d\u2019int\u00e9r\u00eat sp\u00e9ciaux actuels comprennent\u00a0:<\/p>\n<p><\/p>\n<p><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-41c64eb elementor-widget elementor-widget-n-accordion\" data-id=\"41c64eb\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;default_state&quot;:&quot;expanded&quot;,&quot;max_items_expended&quot;:&quot;one&quot;,&quot;n_accordion_animation_duration&quot;:{&quot;unit&quot;:&quot;ms&quot;,&quot;size&quot;:400,&quot;sizes&quot;:[]}}\" data-widget_type=\"nested-accordion.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"e-n-accordion\" aria-label=\"Accord\u00e9on. Ouvrir les liens avec Entr\u00e9e ou Espace, fermer avec \u00c9chap et naviguer avec les touches fl\u00e9ch\u00e9es\">\n\t\t\t\t\t\t<details id=\"Alcohol-Related-Liver-Disease-SIG\" class=\"e-n-accordion-item\" open>\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"1\" tabindex=\"0\" aria-expanded=\"true\" aria-controls=\"Alcohol-Related-Liver-Disease-SIG\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Groupe d&#039;int\u00e9r\u00eat sp\u00e9cial sur les maladies h\u00e9patiques li\u00e9es \u00e0 l&#039;alcool <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"Alcohol-Related-Liver-Disease-SIG\" class=\"elementor-element elementor-element-3a98e4f e-con-full e-flex e-con e-child\" data-id=\"3a98e4f\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div role=\"region\" aria-labelledby=\"Alcohol-Related-Liver-Disease-SIG\" class=\"elementor-element elementor-element-0693ff9 e-flex e-con-boxed e-con e-child\" data-id=\"0693ff9\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-40ad93c elementor-widget elementor-widget-text-editor\" data-id=\"40ad93c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Cr\u00e9\u00e9 en 2020, le SIG sur les maladies du foie li\u00e9es \u00e0 l&#039;alcool vise \u00e0 am\u00e9liorer les r\u00e9sultats des patients atteints d&#039;une maladie du foie li\u00e9e \u00e0 l&#039;alcool.<\/p>\n<p><strong>\u00c9nonc\u00e9 de mission : <\/strong><em style=\"font-size: 16px;\">Notre mission est de mieux comprendre et g\u00e9rer les maladies du foie li\u00e9es \u00e0 l\u2019alcool, gr\u00e2ce \u00e0 une recherche collaborative de pointe et \u00e0 d\u2019excellents soins cliniques. <\/em><em style=\"font-size: 16px;\">Nous sommes un groupe multidisciplinaire, comprenant des h\u00e9patologues, des m\u00e9decins sp\u00e9cialis\u00e9s en toxicomanie et des professionnels param\u00e9dicaux. <\/em><em style=\"font-size: 16px;\">Nous croyons en une recherche centr\u00e9e sur le patient et qui aborde \u00e9galement les d\u00e9terminants sociaux de la sant\u00e9.<\/em><span style=\"font-size: 16px;\">\u00a0<\/span><em style=\"font-size: 16px;\">Si vous avez des questions, veuillez nous contacter via\u00a0<a href=\"mailto:casl@hepatology.ca\" target=\"_blank\" rel=\"noopener\">e-mail<\/a>.<\/em><\/p>\n<p><strong>Projets de recherche en cours :<\/strong><\/p>\n<ul>\n<li>Suppl\u00e9mentation nutritionnelle dans le traitement de l&#039;h\u00e9patite alcoolique : une revue r\u00e9trospective multicentrique<\/li>\n<li>Traitement des troubles li\u00e9s \u00e0 la consommation d&#039;alcool chez les patients atteints d&#039;h\u00e9patite alcoolique<\/li>\n<\/ul>\n<p><strong>Chefs de groupe :<\/strong><\/p>\n<div class=\"wp-block-group\">\n<div class=\"wp-block-group\">\n<ul>\n<li>Cynthia Tsien<\/li>\n<li>Tasha Kulai<\/li>\n<\/ul>\n<p><strong>Membres en g\u00e9n\u00e9ral :<\/strong><\/p>\n<ul>\n<li>Mayur Brahmania (Occidental)<\/li>\n<li>Lisa Bromley (Ottawa)<\/li>\n<li>Angela Cheung (Ottawa)<\/li>\n<li>Nabiha Faisal (Manitoba)<\/li>\n<li>Monty Ghosh (Calgary)<\/li>\n<li>Hin Hin Ko (UBC)<\/li>\n<li>Elizabeth Lee (R\u00e9seau universitaire de sant\u00e9)<\/li>\n<li>Jon Mong (Ottawa)<\/li>\n<li>Keyur Patel (R\u00e9seau universitaire de sant\u00e9)<\/li>\n<li>Jennifer Prentice<\/li>\n<li>Puneeta Tandon (Alberta)<\/li>\n<li>Kim Treuil (Ottawa)<\/li>\n<li>David K. Wong (R\u00e9seau universitaire de sant\u00e9)<\/li>\n<\/ul>\n<\/div>\n<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"Canadian-HBV-Network\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"2\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"Canadian-HBV-Network\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> R\u00e9seau canadien sur le VHB <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"Canadian-HBV-Network\" class=\"elementor-element elementor-element-af41fe6 e-con-full e-flex e-con e-child\" data-id=\"af41fe6\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div role=\"region\" aria-labelledby=\"Canadian-HBV-Network\" class=\"elementor-element elementor-element-1e580d2 e-flex e-con-boxed e-con e-child\" data-id=\"1e580d2\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-e8e54eb elementor-widget elementor-widget-text-editor\" data-id=\"e8e54eb\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h5><strong>Qui sommes-nous<\/strong><\/h5>\n<p>Le R\u00e9seau canadien sur le VHB est une organisation collaborative de professionnels de la sant\u00e9 et de chercheurs de partout au Canada qui s&#039;int\u00e9ressent \u00e0 l&#039;avancement de l&#039;excellence dans les soins, la recherche et l&#039;\u00e9ducation des patients atteints d&#039;h\u00e9patite B. Le r\u00e9seau est compos\u00e9 de professionnels de la sant\u00e9 et de chercheurs de 22 cliniques universitaires et communautaires de huit provinces canadiennes, de laboratoires provinciaux et du Laboratoire national de microbiologie \/ Agence de la sant\u00e9 publique du Canada. Le R\u00e9seau canadien sur le VHB est soutenu par des chercheurs multidisciplinaires en sciences fondamentales \/ biom\u00e9dicales, des cliniciens-chercheurs, des microbiologistes m\u00e9dicaux, des virologues cliniques, des \u00e9pid\u00e9miologistes, des biostatisticiens et des \u00e9conomistes de la sant\u00e9.<\/p>\n<h5><strong>Mission<\/strong><\/h5>\n<ul>\n<li>Am\u00e9liorer le traitement et le contr\u00f4le de l\u2019h\u00e9patite B au Canada<\/li>\n<li>Promouvoir la collaboration sur les \u00e9tudes et bases de donn\u00e9es nationales sur le VHB<\/li>\n<li>Am\u00e9liorer la compr\u00e9hension des processus et de l\u2019histoire naturelle de la maladie de l\u2019h\u00e9patite B<\/li>\n<\/ul>\n<h5><strong>Personnes-ressources, institutions et contacts<\/strong><\/h5>\n<p>Les membres du comit\u00e9 directeur 2024-2027 sont :<\/p>\n<ul>\n<li>Dr Edward Tam \u2013 Pacific Gastroenterology Associates<\/li>\n<li>Dre Emma Lee \u2013 Laboratoire national de microbiologie \/ Agence de la sant\u00e9 publique du Canada<\/li>\n<li>Dre Angela Crawley \u2013 Institut de recherche de l\u2019h\u00f4pital d\u2019Ottawa<\/li>\n<li>Dr Adam Gehring \u2013 Universit\u00e9 de Toronto<\/li>\n<li>Dr Tianyan Chen \u2013 Universit\u00e9 McGill<\/li>\n<li>Dre Carla Coffin \u2013 Universit\u00e9 de Calgary Une liste de tous les membres du r\u00e9seau est disponible \u00e0 l\u2019adresse https:\/\/canadianhbvnetwork.ca\/members<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"CPHRG\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"3\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"CPHRG\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Groupe canadien de recherche en h\u00e9patologie p\u00e9diatrique <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"CPHRG\" class=\"elementor-element elementor-element-4cc7b66 e-con-full e-flex e-con e-child\" data-id=\"4cc7b66\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div role=\"region\" aria-labelledby=\"CPHRG\" class=\"elementor-element elementor-element-bb785e6 e-flex e-con-boxed e-con e-child\" data-id=\"bb785e6\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-506ae94 elementor-widget elementor-widget-text-editor\" data-id=\"506ae94\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h5><strong>Domaine d&#039;int\u00e9r\u00eat : H\u00e9patologie p\u00e9diatrique<\/strong><\/h5>\n<p>Le CPHRG est un r\u00e9seau d\u2019h\u00e9patologues p\u00e9diatriques \u00e0 travers le Canada dont la mission est de collaborer \u00e0 la recherche sur les maladies du foie p\u00e9diatriques et de plaider en faveur de l\u2019optimisation des soins cliniques des enfants et des jeunes atteints d\u2019une maladie du foie.<\/p>\n<p>Les r\u00e9unions du CPHRG ont lieu une fois par an pendant la r\u00e9union annuelle de l&#039;ACL pour discuter des projets de recherche en cours et futurs.<\/p>\n<h5><strong>Projets en cours :<\/strong><\/h5>\n<ul>\n<li>Cholestase intrah\u00e9patique g\u00e9n\u00e9tique : troubles p\u00e9diatriques entra\u00eenant un dysfonctionnement des canaux biliaires au Canada<\/li>\n<li>Le fardeau de l\u2019infection chronique par l\u2019h\u00e9patite C chez les enfants au Canada et l\u2019efficacit\u00e9 p\u00e9diatrique \u00ab dans le monde r\u00e9el \u00bb des nouvelles th\u00e9rapies<\/li>\n<\/ul>\n<h5><strong>Projets pass\u00e9s:<\/strong><\/h5>\n<ul>\n<li>\u00c9tude r\u00e9trospective nationale sur les maladies h\u00e9patiques p\u00e9diatriques terminales comme facteur pr\u00e9dictif du passage \u00e0 un traitement de deuxi\u00e8me intention chez les enfants atteints d&#039;h\u00e9patite auto-immune. Zizzo AN, Jimenez-Rivera C, Kim J, Schreiber RA, Ling SC, Yap J8, Critch J, Ahmed N, Alvarez F, Kamath BM; Institut canadien de p\u00e9diatrie<\/li>\n<li>Groupe de recherche en h\u00e9patologie (CPHRG). Liver Int. 2017 Oct;37(10):1562-1570.doi: 10.1111\/liv.13387.Epub 2017 Mar 15.<\/li>\n<li>Incidence et caract\u00e9ristiques de l&#039;h\u00e9patite auto-immune. Jimenez-Rivera C, Ling SC, Ahmed N, Yap J, Aglipay M, Barrowman N, Graitson S, Critch J, Rashid M, Ng VL, Roberts EA, Brill H, Dowhaniuk JK, Bruce G, Bax K, Deneau M, Guttman OR, Schreiber RA, Martin S, Alvarez F. Pediatrics. 2015 Nov;136(5):e1237-48.doi:10.1542\/peds.2015-0578. Epub 2015 Oct 19.<\/li>\n<li>Atr\u00e9sie biliaire avec malformations structurelles associ\u00e9es chez les nourrissons canadiens. Guttman OR1, Roberts EA, Schreiber RA, Barker CC, Ng VL;<\/li>\n<li>Groupe canadien de recherche en h\u00e9patologie p\u00e9diatrique. Liver Int. 2011 nov.;31(10):1485-93. doi:10.1111\/j.1478-3231.2011.02578.s. Publication en ligne le 8 ao\u00fbt 2011<\/li>\n<li>Atr\u00e9sie biliaire au Canada : l&#039;effet de l&#039;exp\u00e9rience du centre sur les r\u00e9sultats. Schreiber RA1, Barker CC, Roberts EA, Martin SR;<\/li>\n<li>Groupe de recherche en h\u00e9patologie p\u00e9diatrique. J Pediatr Gastroenterol Nutr. 2010 juill.;51(1):61-5. doi: 10.1097\/MPG.0b013e3181d67e5e.<\/li>\n<li>Atr\u00e9sie biliaire : l&#039;exp\u00e9rience canadienne.Schreiber RA, Barker CC, Roberts EA, Martin SR, Alvarez F, Smith L, Butzner JD, Wrobel I, Mack D, Moroz S, Rashid M, Persad R, Levesque D, Brill H, Bruce G, Critch J;<\/li>\n<li>Groupe de recherche en h\u00e9patologie p\u00e9diatrique. J Pediatr. 2007 d\u00e9c.;151(6):659-65, 665.e1. Publication en ligne le 22 octobre 2007.<\/li>\n<\/ul>\n<h5><strong>Coordonn\u00e9es des prospects et des membres du groupe<\/strong><\/h5>\n<ul>\n<li>Carolina Jimenez cajimenez@cheo.on.ca (Pr\u00e9sidente)<\/li>\n<li>Andr\u00e9anne Zizzo andreanne.zizzo@lhsc.on.ca<\/li>\n<li>Anna Wieckowska anna.wieckowska@mail.chudequebec.ca<\/li>\n<li>Ashok Dandhapani dhandapani.ashok@lhsc.on.ca<\/li>\n<li>Binita Kamath binita.kamath@sickkids.ca<\/li>\n<li>Decker Butzner butzner@ucalgary.ca<\/li>\n<li>Eve Roberts eve.roberts@sickkids.ca<\/li>\n<li>Fernando Alvarez fernando.alvarez@umontreal.ca<\/li>\n<li>Guttman, Orlee oguttman@cw.bc.ca<\/li>\n<li>Herbert Brill brillh@mcmaster.ca<\/li>\n<li>Jeff Critch habs19@nf.sympatico.ca<\/li>\n<li>Massimiliano Paganelli m.paganelli@umontreal.ca<\/li>\n<li>Mohit Kehar mohit.kehar@kingstonhsc.ca<\/li>\n<li>Mohsin Rashid mohsin.rashid@iwk.nshealth.ca<\/li>\n<li>Najma Ahmed najma.ahmed@mcgill.ca<\/li>\n<li>Patricia Kawada patricia.kawada@albertahealthservices.ca<\/li>\n<li>Pushpa Sathya pushpa.sathya5@gmail.com<\/li>\n<li>Rick Schreiber, rschreiber@cw.bc.ca<\/li>\n<li>Simon Ling simon.ling@sickkids.ca<\/li>\n<li>Steve Martin stevenR.martin@albertahealthservices.ca<\/li>\n<li>Susan Gilmour susan.gilmour@albertahealthservices.ca<\/li>\n<li>Vicky Ng vicky.ng@sickkids.ca<\/li>\n<li>Quais Mujawar qmujawar@exchange.hsc.mb.ca<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"CanMASLD\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"4\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"CanMASLD\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> R\u00e9seau canadien MASLD (CanMASLD) <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"CanMASLD\" class=\"elementor-element elementor-element-ab715d9 e-con-full e-flex e-con e-child\" data-id=\"ab715d9\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div role=\"region\" aria-labelledby=\"CanMASLD\" class=\"elementor-element elementor-element-2466e2c e-flex e-con-boxed e-con e-child\" data-id=\"2466e2c\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-8c12600 elementor-widget elementor-widget-text-editor\" data-id=\"8c12600\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h5><strong>Qui sommes-nous<\/strong><\/h5>\n<p>Le r\u00e9seau canadien MASLD est une organisation collaborative de professionnels de la sant\u00e9 de partout au Canada dont l&#039;int\u00e9r\u00eat principal est d&#039;am\u00e9liorer la compr\u00e9hension, les soins, l&#039;\u00e9ducation et la recherche chez les personnes atteintes de maladie h\u00e9patique st\u00e9atosique associ\u00e9e \u00e0 un dysfonctionnement m\u00e9tabolique (MASLD) (anciennement NAFLD) en se concentrant sur l&#039;\u00e9pid\u00e9miologie, le diagnostic, le traitement et la pr\u00e9vention. Veuillez visiter https:\/\/canmasld.org\/ pour plus d&#039;informations.<\/p>\n<h5><strong>Mission<\/strong><\/h5>\n<ul>\n<li>Augmenter la capacit\u00e9 de recherche et r\u00e9pondre aux questions de recherche cliniquement pertinentes gr\u00e2ce au partage de donn\u00e9es et de ressources.<\/li>\n<li>D\u00e9fendre les int\u00e9r\u00eats des groupes de patients par le biais de conseils consultatifs communautaires, de r\u00e9unions politiques avec les organismes gouvernementaux et d\u2019appels \u00e0 l\u2019action de groupes multipartites.<\/li>\n<li>\u00c9ducation par le biais d\u2019\u00e9v\u00e9nements communautaires et de partenariats avec des m\u00e9decins de soins primaires qui am\u00e9liorent la compr\u00e9hension des options de pr\u00e9vention et de soins.<\/li>\n<\/ul>\n<h5>Personnes-ressources, institutions et contacts<\/h5>\n<p>Les membres du comit\u00e9 directeur de CanMASLD sont :<\/p>\n<ul>\n<li>Dr Mark Swain \u2013 Universit\u00e9 de Calgary<\/li>\n<li>Dre Giada Sebastiani \u2013 Universit\u00e9 McGill<\/li>\n<li>Dr Alnoor Ramji \u2013 Universit\u00e9 de la Colombie-Britannique<\/li>\n<li>Dr Keyur Patel \u2013 Universit\u00e9 de Toronto<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"CaNAL\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"5\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"CaNAL\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Maladies auto-immunes du foie \/ Registre CaNaL <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"CaNAL\" class=\"elementor-element elementor-element-55f9efe e-con-full e-flex e-con e-child\" data-id=\"55f9efe\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div role=\"region\" aria-labelledby=\"CaNAL\" class=\"elementor-element elementor-element-bdea5b6 e-flex e-con-boxed e-con e-child\" data-id=\"bdea5b6\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-160b2bf elementor-widget elementor-widget-text-editor\" data-id=\"160b2bf\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h5><strong>\u00c0 propos de CaNAL<\/strong><\/h5>\n<p>Le R\u00e9seau canadien pour les maladies auto-immunes du foie (CaNAL) est une \u00e9tude de cohorte observationnelle longitudinale de patients diagnostiqu\u00e9s avec une cholangite biliaire primitive (CBP), une h\u00e9patite auto-immune (HAI) ou un syndrome de chevauchement. Ce registre national se concentre sur le suivi \u00e0 long terme de haute qualit\u00e9 de patients individuels provenant de grands centres canadiens, dont le Toronto Centre for Liver Disease (TCLD). L&#039;objectif principal du CaNAL est de cr\u00e9er un registre canadien de patients atteints de CBP, d&#039;HAI et du syndrome de chevauchement afin de permettre de nouvelles perspectives sur les maladies auto-immunes du foie. Comme ces maladies sont rares et progressent lentement, ce type d&#039;approche \u00e0 grande \u00e9chelle aidera \u00e0 am\u00e9liorer notre compr\u00e9hension en fournissant des informations sur le d\u00e9veloppement de la maladie et en identifiant les facteurs de risque associ\u00e9s \u00e0 des r\u00e9sultats importants. Des variables telles que les donn\u00e9es d\u00e9mographiques des patients, la qualit\u00e9 de vie et les r\u00e9sultats des patients sont collect\u00e9es pour permettre l&#039;identification de biomarqueurs. Cela peut aider \u00e0 pr\u00e9dire la progression de la maladie ou la non-r\u00e9ponse au traitement, ainsi qu&#039;\u00e0 faciliter le diagnostic pr\u00e9coce de la maladie auto-immune du foie afin d&#039;assurer un traitement rapide et de pr\u00e9venir la progression de la maladie.<\/p>\n<h5><strong>Comit\u00e9 de pilotage<\/strong><\/h5>\n<p>Gideon Hirschfield<br \/>Bettina Hansen<br \/>Aliya Gulahusein<br \/>Julien Hercun<br \/>Andrew Mason<br \/>Aldo Montano-Loza<br \/>Mark Swain<br \/>Hin Hin Ko<\/p>\n<h5><strong>Publications r\u00e9centes<\/strong><\/h5>\n<p><strong><br \/>La perte de la r\u00e9ponse biochimique \u00e0 tout moment aggrave les r\u00e9sultats chez les patients atteints de cholangite biliaire primitive trait\u00e9s par UDCA<\/strong> Roberts SB, Choi WJ, Worobetz L, Vincent C, Flemming JA, Cheung A, Qumosani K, Swain M, Grbic D, Ko HH, Peltekian KM, Abrahamyan L, Saini M, Tirona K, Aziz B, Lytvyak E, Invernizzi P , Ponsioen CY, Bruns T, Cazzagon N, Lindor K, Dalekos GN, Gatselis NK, Verhelst X, Floreani A, Corpechot C, Mayo MJ, Levy C, Londo\u00f1o MC, Battezzati PM, Pares A, Nevens F, van der Meer A, Kowdley KV, Trivedi PJ, Lleo A, Thorburn D, Carbone M, Selzner N, Gulamhusein AF, Janssen H, Montano-Loza AJ, Mason AL, Hirschfield GM, Hansen BE\u00a0; R\u00e9seau canadien sur les maladies auto-immunes du foie (CaNAL). JHEP Rep. 8 juillet 2024;6(10):101168. Lien: <a href=\"https:\/\/www.jhep-reports.eu\/article\/S2589-5559(24)00172-1\/fulltext\" target=\"_blank\" rel=\"noopener\">https:\/\/www.jhep-reports.eu\/article\/S2589-5559(24)00172-1\/fulltext<\/a><\/p>\n<p><strong>R\u00e9ponse au traitement et survie sans \u00e9v\u00e9nement clinique dans l&#039;h\u00e9patite auto-immune : une \u00e9tude de cohorte multicentrique canadienne<\/strong> Plagiannakos CG, Hirschfield GM, Lytvyak E, Roberts SB, Ismail M, Gulamhusein AF, Selzner N, Qumosani KM, Worobetz L, Hercun J, Vincent C, Flemming JA, Swain MG, Cheung A, Chen T, Grbic D, Peltekain K, Mason AL, Montano-Loza AJ, Hansen BE; R\u00e9seau canadien pour les maladies auto-immunes du foie (CaNAL). J Hepatol. Ao\u00fbt 2024;81(2):227-237. Lien: <a href=\"https:\/\/www.journal-of-hepatology.eu\/article\/S0168-8278(24)00205-8\/fulltext\" target=\"_blank\" rel=\"noopener\">https:\/\/www.journal-of-hepatology.eu\/article\/S0168-8278(24)00205-8\/fulltext<\/a><\/p>\n<p><strong>Ethnicit\u00e9, gravit\u00e9 de la maladie et survie des patients canadiens atteints de cholangite biliaire primitive<\/strong> Roberts SB, Hirschfield GM, Worobetz LJ, Vincent C, Flemming JA, Cheung A, Qumosani K, Swain M, Grbic D, Ko HH, Peltekian K, Selzner N, Abrahamyan L, Aziz B, Lytvyak E, Tirona K, Gulamhusein AF, Janssen HLA, Montano-Loza AJ, Mason AL, Hansen BE; R\u00e9seau canadien pour les maladies auto-immunes du foie (CaNAL). H\u00e9patologie. Ao\u00fbt 2022;76(2):303-316. Lien: <a href=\"https:\/\/journals.lww.com\/hep\/abstract\/2022\/08000\/ethnicity,_disease_severity,_and_survival_in.7.aspx\" target=\"_blank\" rel=\"noopener\">https:\/\/journals.lww.com\/hep\/abstract\/2022\/08000\/ethnicity,_disease_severity,_and_survival_in.7.aspx<\/a><\/p>\n<p><strong>Efficacit\u00e9 r\u00e9elle de l\u2019acide ob\u00e9ticholique chez les patients atteints de cholangite biliaire primitive.<\/strong> Roberts SB, Ismail M, Kanagalingam G, Mason AL, Swain MG, Vincent C, Yoshida EM, Tsien C, Flemming JA, Janssen HLA, Hirschfield GM, Hansen BE, Gulamhusein AF; R\u00e9seau canadien pour les maladies auto-immunes du foie. Hepatol Commun. 6 juillet 2020;4(9):1332-1345. Lien : <a href=\"https:\/\/journals.lww.com\/hepcomm\/fulltext\/2020\/09000\/real_world_effectiveness_of_obeticholic_acid_in.10.aspx\" target=\"_blank\" rel=\"noopener\">https:\/\/journals.lww.com\/hepcomm\/fulltext\/2020\/09000\/real_world_effectiveness_of_obeticholic_acid_in.10.aspx<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"Complications-of-Cirrhosis-Group\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"6\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"Complications-of-Cirrhosis-Group\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Groupe des complications de la cirrhose <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"Complications-of-Cirrhosis-Group\" class=\"elementor-element elementor-element-66bf378 e-con-full e-flex e-con e-child\" data-id=\"66bf378\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div role=\"region\" aria-labelledby=\"Complications-of-Cirrhosis-Group\" class=\"elementor-element elementor-element-bde2568 e-flex e-con-boxed e-con e-child\" data-id=\"bde2568\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"Pediatric-Hepatology\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"7\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"Pediatric-Hepatology\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Groupe d&#039;h\u00e9patologie p\u00e9diatrique <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"Pediatric-Hepatology\" class=\"elementor-element elementor-element-2da957f e-con-full e-flex e-con e-child\" data-id=\"2da957f\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div role=\"region\" aria-labelledby=\"Pediatric-Hepatology\" class=\"elementor-element elementor-element-82ddcc3 e-flex e-con-boxed e-con e-child\" data-id=\"82ddcc3\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-ce3c6ec elementor-widget elementor-widget-text-editor\" data-id=\"ce3c6ec\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Le Groupe de recherche canadien en h\u00e9patologie p\u00e9diatrique (GRCPH) est un r\u00e9seau d&#039;h\u00e9patologues p\u00e9diatriques \u00e0 travers le Canada dont la mission est de collaborer \u00e0 la recherche sur les maladies du foie p\u00e9diatriques et de plaider en faveur de l&#039;optimisation des soins cliniques des enfants et des jeunes atteints d&#039;une maladie du foie.<\/p>\n<p>Le Groupe de recherche canadien en h\u00e9patologie p\u00e9diatrique (GRCPH) est un r\u00e9seau d\u2019h\u00e9patologues p\u00e9diatriques de partout au Canada qui se consacre \u00e0 l\u2019avancement de la recherche sur les maladies h\u00e9patiques p\u00e9diatriques et \u00e0 la promotion de meilleurs soins cliniques pour les enfants et les jeunes touch\u00e9s par des maladies h\u00e9patiques. Compos\u00e9 de tous les \u00e9tablissements universitaires du Canada, le GRCPH favorise la collaboration et le partage des connaissances entre les \u00e9tablissements afin de stimuler l\u2019innovation et d\u2019am\u00e9liorer les r\u00e9sultats en h\u00e9patologie p\u00e9diatrique. Les r\u00e9unions du GRCPH ont lieu une fois par an pendant la r\u00e9union annuelle du Canadian Liver Meeting pour discuter des projets de recherche en cours et \u00e0 venir.<\/p>\n<p><strong>Projets en cours\/futurs : <br \/><\/strong>Cholestase intrah\u00e9patique g\u00e9n\u00e9tique au Canada : troubles p\u00e9diatriques entra\u00eenant un dysfonctionnement des canaux biliaires. Le groupe vise \u00e0 \u00e9tablir un registre national pour recueillir syst\u00e9matiquement des donn\u00e9es sur les patients atteints de cholestase g\u00e9n\u00e9tique. Ce registre contribuera \u00e0 am\u00e9liorer la compr\u00e9hension de l\u2019histoire naturelle de ces affections et \u00e0 \u00e9valuer l\u2019impact des th\u00e9rapies \u00e9mergentes.<\/p>\n<p><strong>Projets pass\u00e9s:<\/strong><\/p>\n<ul>\n<li>\u00c9tude r\u00e9trospective nationale sur les maladies h\u00e9patiques p\u00e9diatriques terminales comme facteur pr\u00e9dictif de changement de traitement de deuxi\u00e8me intention chez les enfants atteints d&#039;h\u00e9patite auto-immune. Zizzo AN, Jimenez-Rivera C, Kim J, Schreiber RA, Ling SC, Yap J8, Critch J, Ahmed N, Alvarez F, Kamath BM; Groupe de recherche canadien en h\u00e9patologie p\u00e9diatrique (GRCPH). Liver Int. 2017 octobre;37(10):1562-1570.doi: 10.1111\/liv.13387.Epub 2017 mars 15.<br \/><br \/><\/li>\n<li>Incidence et caract\u00e9ristiques de l&#039;h\u00e9patite auto-immune. Jimenez-Rivera C, Ling SC, Ahmed N, Yap J, Aglipay M, Barrowman N, Graitson S, Critch J, Rashid M, Ng VL, Roberts EA, Brill H, Dowhaniuk JK, Bruce G, Bax K, Deneau M, Guttman OR, Schreiber RA, Martin S, Alvarez F. Pediatrics. 2015 Nov;136(5):e1237-48.doi:10.1542\/peds.2015-0578. Epub 2015 Oct 19.<br \/><br \/><\/li>\n<li>Atr\u00e9sie biliaire associ\u00e9e \u00e0 des malformations structurelles chez les nourrissons canadiens. Guttman OR, Roberts EA, Schreiber RA, Barker CC, Ng VL; Groupe canadien de recherche en h\u00e9patologie p\u00e9diatrique. Liver Int. 2011 nov.;31(10):1485-93. doi:10.1111\/j.1478-3231.2011.02578.s. Publication en ligne du 8 ao\u00fbt 2011<br \/><br \/><\/li>\n<li>Atr\u00e9sie biliaire au Canada : l&#039;effet de l&#039;exp\u00e9rience du nombre de cas dans le centre sur les r\u00e9sultats. Schreiber RA, Barker CC, Roberts EA, Martin SR; Groupe canadien de recherche en h\u00e9patologie p\u00e9diatrique. J Pediatr Gastroenterol Nutr. 2010 juill;51(1):61-5. doi: 10.1097\/MPG.0b013e3181d67e5e.<br \/><br \/><\/li>\n<li>Atr\u00e9sie biliaire : l&#039;exp\u00e9rience canadienne. Schreiber RA, Barker CC, Roberts EA, Martin SR, Alvarez F, Smith L, Butzner JD, Wrobel I, Mack D, Moroz S, Rashid M, Persad R, Levesque D, Brill H, Bruce G, Critch J; Groupe canadien de recherche en h\u00e9patologie p\u00e9diatrique. J Pediatr. 2007 d\u00e9c.;151(6):659-65, 665.e1. Publication \u00e9lectronique 2007 oct. 22.<\/li>\n<\/ul>\n<p><strong>Responsables et membres du groupe<\/strong><\/p>\n<ul>\n<li>Carolina Jimenez (Pr\u00e9sidente)<\/li>\n<li>Najma Ahmed<\/li>\n<li>Fernando \u00c1lvarez<\/li>\n<li>Herbert Brill<\/li>\n<li>Marie-\u00c8ve Chartier<\/li>\n<li>Gillermo Costaguta<\/li>\n<li>Jeff Critch<\/li>\n<li>Ashok Dhandapani<\/li>\n<li>Marie Flanagan<\/li>\n<li>Susan Gilmore<\/li>\n<li>Patricia Kawada<\/li>\n<li>Mohit Kehar<\/li>\n<li>Simone Korbeek<\/li>\n<li>Simon Lam<\/li>\n<li>Simon Ling<\/li>\n<li>Mar Miserachs<\/li>\n<li>Quais Mujawar<\/li>\n<li>Vicky Ng<\/li>\n<li>Orlee Guttman<\/li>\n<li>Massimiliano Paganelli<\/li>\n<li>Mohsin Rashid<\/li>\n<li>Eve Roberts<\/li>\n<li>Pushpa Sathya<\/li>\n<li>Rick Schrieber<\/li>\n<li>Anna Wieckowska<\/li>\n<li>Kerry Wong<\/li>\n<li>Andr\u00e9anne Zizzo<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"transplant\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"8\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"transplant\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Groupe de transplantation <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"transplant\" class=\"elementor-element elementor-element-4e8c649 e-con-full e-flex e-con e-child\" data-id=\"4e8c649\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div role=\"region\" aria-labelledby=\"transplant\" class=\"elementor-element elementor-element-06736c7 e-flex e-con-boxed e-con e-child\" data-id=\"06736c7\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-fb56696 elementor-widget elementor-widget-text-editor\" data-id=\"fb56696\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h5><strong>Vision<\/strong><\/h5>\n<p>\u00catre le groupe de recherche collaborative sur la transplantation h\u00e9patique au Canada<\/p>\n<h5><strong>Mission<\/strong><\/h5>\n<p>Favoriser et mener des recherches collaboratives sur la transplantation h\u00e9patique partout au Canada<\/p>\n<h5><strong>Qui sommes-nous<\/strong><\/h5>\n<p>Le groupe d&#039;int\u00e9r\u00eat sur la transplantation h\u00e9patique de l&#039;ACL est ouvert \u00e0 tous les cliniciens et chercheurs de l&#039;ACL int\u00e9ress\u00e9s par la transplantation h\u00e9patique. Les membres de l&#039;ACL int\u00e9ress\u00e9s doivent contacter la personne-ressource de leur \u00e9tablissement (voir ci-dessous) pour obtenir de plus amples renseignements.<\/p>\n<h5><strong>Ce que nous faisons<\/strong><\/h5>\n<p>Le groupe d&#039;int\u00e9r\u00eat sur la transplantation h\u00e9patique de la CASL se r\u00e9unit au moins deux fois par an, g\u00e9n\u00e9ralement au CDDW et \u00e0 l&#039;AASLD. Ces r\u00e9unions servent \u00e0<\/p>\n<ul>\n<li>Examiner les progr\u00e8s\/r\u00e9sultats des projets de recherche collaborative en cours<\/li>\n<li>Proposer\/pr\u00e9senter de nouveaux projets de recherche<\/li>\n<li>Discuter d\u2019autres questions d\u2019int\u00e9r\u00eat commun li\u00e9es \u00e0 la transplantation<\/li>\n<\/ul>\n<h5><strong>Projets en cours<\/strong><\/h5>\n<ul>\n<li>Efficacit\u00e9 du traitement antiviral \u00e0 base de sofosbuvir dans le traitement de l\u2019h\u00e9patite C r\u00e9currente apr\u00e8s une transplantation h\u00e9patique \u2013 une \u00e9tude observationnelle pancanadienne<\/li>\n<li>Indice de masse corporelle et r\u00e9sultats de la transplantation h\u00e9patique \u2013 une analyse r\u00e9trospective pancanadienne<\/li>\n<\/ul>\n<h5><strong>Projets pancanadiens ant\u00e9rieurs\u00a0<\/strong>(exemples)<\/h5>\n<ul>\n<li><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12783400\" target=\"_blank\" rel=\"noopener\">Sevrage pr\u00e9coce des st\u00e9ro\u00efdes apr\u00e8s une transplantation h\u00e9patique : essai canadien comparant le tacrolimus \u00e0 la cyclosporine A en micro\u00e9mulsion : suivi d&#039;un an.<\/a>\u00a0Greig P, Lilly L, Scudamore C, Erb S, Yoshida E, Kneteman N, Bain V, Ghent C, Marotta P, Grant D, Wall W, Tchervenkov J, Barkun J, Roy A, Marleau D, McAlister V, Peltekian K . Transpl. 2003;9:587-95.<\/li>\n<li><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16123958\" target=\"_blank\" rel=\"noopener\">\u00c9valuation de la fonction r\u00e9nale chez les receveurs de greffe de foie recevant du daclizumab (Zenapax), du mycoph\u00e9nolate mof\u00e9til et un sch\u00e9ma th\u00e9rapeutique \u00e0 faible dose de tacrolimus retard\u00e9 par rapport \u00e0 un sch\u00e9ma th\u00e9rapeutique \u00e0 dose standard de tacrolimus et de mycoph\u00e9nolate mof\u00e9til : un essai clinique randomis\u00e9 multicentrique.<\/a>\u00a0Yoshida EM, Marotta PJ, Greig PD, Kneteman NM, Marleau D, Cantarovich M, Peltekian KM, Lilly LB, Scudamore CH, Bain VG, Wall WJ, Roy A, Balshaw RF, Barkun JS. Transpl. 2005;11:1064-72.<\/li>\n<li><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17111055\" target=\"_blank\" rel=\"noopener\">H\u00e9patite C r\u00e9currente apr\u00e8s transplantation : o\u00f9 en sommes-nous et que pouvons-nous faire \u00e0 partir de maintenant ? Un rapport de l&#039;atelier canadien d&#039;h\u00e9patologie de transplantation.<\/a>\u00a0Watt KD, Burak K, Desch\u00eanes M, Lilly L, Marleau D, Marotta P, Mason A, Peltekian KM, Renner EL, Yoshida EM; R\u00e9seau canadien de recherche sur les r\u00e9sultats en h\u00e9patologie des transplantations. Can J Gastroenterol. 2006;20:725-34.<\/li>\n<li><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18299733\" target=\"_blank\" rel=\"noopener\">La survie apr\u00e8s une transplantation h\u00e9patique pour h\u00e9patite C est rest\u00e9e inchang\u00e9e au Canada depuis deux d\u00e9cennies.<\/a>\u00a0Watt KD, Burak KW, Desch\u00eanes M, Lilly L, Marleau D, Marotta P, Mason A, Peltekian KM, Renner E, Yoshida EM; R\u00e9seau canadien de recherche sur les r\u00e9sultats en h\u00e9patologie des transplantations. Can J Gastroenterol. 2008\u00a0;\u00a022\u00a0:\u00a0153-4.<\/li>\n<li><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18925305\" target=\"_blank\" rel=\"noopener\">Transplantation h\u00e9patique pour h\u00e9mangioendoth\u00e9liome \u00e9pith\u00e9lio\u00efde h\u00e9patique : l&#039;exp\u00e9rience multicentrique canadienne.<\/a>\u00a0Nudo CG, Yoshida EM, Bain VG, Marleau D, Wong P, Marotta PJ, Renner E, Watt KD, Desch\u00eanes M. Can J Gastroenterol. 2008;22:821-4.<\/li>\n<li><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23396740\" target=\"_blank\" rel=\"noopener\">Revue r\u00e9trospective nationale canadienne des dossiers comparant l&#039;effet \u00e0 long terme de la cyclosporine et du tacrolimus sur les r\u00e9sultats cliniques chez les patients infect\u00e9s par le virus de l&#039;h\u00e9patite C apr\u00e8s une transplantation h\u00e9patique.<\/a>\u00a0Yoshida EM, Lilly LB, Marotta PJ, Mason AL, Bilodeau M, Vaillancourt M. Ann Hepatol. 2013;12:282-93.<\/li>\n<li><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25152985\" target=\"_blank\" rel=\"noopener\">La trith\u00e9rapie \u00e0 base d&#039;inhibiteurs de prot\u00e9ase est tr\u00e8s efficace contre la r\u00e9cidive de l&#039;h\u00e9patite C apr\u00e8s une transplantation h\u00e9patique : une exp\u00e9rience multicentrique.<\/a>\u00a0Faisal N, Yoshida EM, Bilodeau M, Wong P, Ma M, Burak KW, Al-Judaibi B, Renner EL, Lilly Ann Hepatol. 2014;13:525-32.<\/li>\n<\/ul>\n<h5><strong>Personnes-ressources, institutions et contacts<\/strong><\/h5>\n<p><strong>Programmes pour adultes<\/strong><\/p>\n<ul>\n<li>Nazia Selzner (Toronto)<\/li>\n<li>Kevork Peltekian (Dalhousie)<\/li>\n<li>Marc Bilodeau, (Montr\u00e9al)<\/li>\n<li>Philippe Wong, (McGill)<\/li>\n<li>Paul Marotta (Ouest)<\/li>\n<li>David Peretz (Manitoba)<\/li>\n<li>Aldo Montano-Loza (Alberta)<\/li>\n<li>Stephen Congly (Calgary)<\/li>\n<li>\u00c9ric Yoshida (UBC)<\/li>\n<\/ul>\n<p><strong>Programmes p\u00e9diatriques<\/strong><\/p>\n<ul>\n<li>Fernando Alvarez (Montr\u00e9al)<\/li>\n<li>Vicki Ng (SickKids)<\/li>\n<li>Jason Yap (Alberta)<\/li>\n<li>Steve Martin (Calgary)<\/li>\n<\/ul>\n<p>Pour plus d\u2019informations, contactez le secr\u00e9taire par int\u00e9rim du groupe d\u2019int\u00e9r\u00eat sur la transplantation de la CASL.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8440363 elementor-widget elementor-widget-text-editor\" data-id=\"8440363\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"font-style: inherit; font-weight: inherit; color: var( --e-global-color-text ); font-family: var( --e-global-typography-text-font-family ), Sans-serif; text-align: var(--text-align); background-color: var(--ast-global-color-5);\">Les groupes d\u2019int\u00e9r\u00eats sp\u00e9ciaux souhaitant \u00eatre approuv\u00e9s par la LCAP doivent fournir un aper\u00e7u des \u00e9l\u00e9ments suivants : <\/span><a style=\"font-style: inherit; font-weight: inherit; font-family: var( --e-global-typography-text-font-family ), Sans-serif; text-align: var(--text-align);\" href=\"mailto:casl@hepatology.ca\">cet email.<\/a><span style=\"font-style: inherit; font-weight: inherit; color: var( --e-global-color-text ); font-family: var( --e-global-typography-text-font-family ), Sans-serif; text-align: var(--text-align); background-color: var(--ast-global-color-5);\">:<\/span><\/p>\n<p>1. Domaine d&#039;\u00e9tude\/Int\u00e9r\u00eat<br \/>2. Br\u00e8ve description<br \/>3. Nombre de r\u00e9unions par an et objet de la r\u00e9union.<br \/>4. Tout projet, en cours, pass\u00e9 ou propos\u00e9<br \/>5. Coordonn\u00e9es des prospects et des membres du groupe<\/p>\n<p>Pour \u00eatre approuv\u00e9, le pr\u00e9sident du groupe d\u2019int\u00e9r\u00eat sp\u00e9cial doit \u00eatre membre de la LCAP.<\/p>\n<p>En tant que groupe d\u2019int\u00e9r\u00eat sp\u00e9cial approuv\u00e9, CASL fournira les services suivants :<\/p>\n<p>1. Acc\u00e8s \u00e0 un espace de r\u00e9union lors de la r\u00e9union canadienne sur le foie chaque ann\u00e9e ou, le cas \u00e9ch\u00e9ant, lors de conf\u00e9rences \u00e0 th\u00e8me unique.<br \/>2. Une liste et une description sur le site Web de la LCAP<br \/>3. Faciliter la communication du SIG entre ses membres.<\/p>\n<p><\/p>\n<p><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Special Interest Groups Policy and Benefits CASL\u00a0is committed to supporting the hepatology community in advancing research and networks to further [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":932,"menu_order":3,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ngg_post_thumbnail":0,"footnotes":""},"class_list":["post-1339","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Special Interest Groups - CASL - Canadian Association for the Study of the Liver<\/title>\n<meta name=\"description\" content=\"We provide official endorsement of Special Interest Groups (SIGs), to promote collaboration of scientists and health care professionals from a range of disciplines who share common specialized interests in the field of hepatology.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hepatology.ca\/fr\/research\/special-interest-groups\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Special Interest Groups - CASL - Canadian Association for the Study of the Liver\" \/>\n<meta property=\"og:description\" content=\"We provide official endorsement of Special Interest Groups (SIGs), to promote collaboration of scientists and health care professionals from a range of disciplines who share common specialized interests in the field of hepatology.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hepatology.ca\/fr\/research\/special-interest-groups\/\" \/>\n<meta property=\"og:site_name\" content=\"CASL - Canadian Association for the Study of the Liver\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-27T18:21:50+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"22 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/hepatology.ca\\\/research\\\/special-interest-groups\\\/\",\"url\":\"https:\\\/\\\/hepatology.ca\\\/research\\\/special-interest-groups\\\/\",\"name\":\"Special Interest Groups - CASL - Canadian Association for the Study of the Liver\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hepatology.ca\\\/#website\"},\"datePublished\":\"2017-01-27T00:01:21+00:00\",\"dateModified\":\"2025-01-27T18:21:50+00:00\",\"description\":\"We provide official endorsement of Special Interest Groups (SIGs), to promote collaboration of scientists and health care professionals from a range of disciplines who share common specialized interests in the field of hepatology.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/hepatology.ca\\\/research\\\/special-interest-groups\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/hepatology.ca\\\/research\\\/special-interest-groups\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/hepatology.ca\\\/research\\\/special-interest-groups\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/hepatology.ca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Research\",\"item\":\"https:\\\/\\\/hepatology.ca\\\/fr\\\/research\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Special Interest Groups\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/hepatology.ca\\\/#website\",\"url\":\"https:\\\/\\\/hepatology.ca\\\/\",\"name\":\"CASL\",\"description\":\"Canada\u2019s home for liver experts\",\"publisher\":{\"@id\":\"https:\\\/\\\/hepatology.ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/hepatology.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/hepatology.ca\\\/#organization\",\"name\":\"Canadian Association for the Study of the Liver\",\"url\":\"https:\\\/\\\/hepatology.ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/hepatology.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/hepatology.ca\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/CASL-logo-transparent-background.png\",\"contentUrl\":\"https:\\\/\\\/hepatology.ca\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/CASL-logo-transparent-background.png\",\"width\":1040,\"height\":294,\"caption\":\"Canadian Association for the Study of the Liver\"},\"image\":{\"@id\":\"https:\\\/\\\/hepatology.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Groupes d&#039;int\u00e9r\u00eats sp\u00e9ciaux - CASL - Association canadienne pour l&#039;\u00e9tude du foie","description":"Nous fournissons une approbation officielle aux groupes d\u2019int\u00e9r\u00eat sp\u00e9ciaux (GIS), afin de promouvoir la collaboration entre scientifiques et professionnels de la sant\u00e9 issus de diverses disciplines qui partagent des int\u00e9r\u00eats sp\u00e9cialis\u00e9s communs dans le domaine de l\u2019h\u00e9patologie.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hepatology.ca\/fr\/research\/special-interest-groups\/","og_locale":"fr_CA","og_type":"article","og_title":"Special Interest Groups - CASL - Canadian Association for the Study of the Liver","og_description":"We provide official endorsement of Special Interest Groups (SIGs), to promote collaboration of scientists and health care professionals from a range of disciplines who share common specialized interests in the field of hepatology.","og_url":"https:\/\/hepatology.ca\/fr\/research\/special-interest-groups\/","og_site_name":"CASL - Canadian Association for the Study of the Liver","article_modified_time":"2025-01-27T18:21:50+00:00","twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"22 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/hepatology.ca\/research\/special-interest-groups\/","url":"https:\/\/hepatology.ca\/research\/special-interest-groups\/","name":"Groupes d&#039;int\u00e9r\u00eats sp\u00e9ciaux - CASL - Association canadienne pour l&#039;\u00e9tude du foie","isPartOf":{"@id":"https:\/\/hepatology.ca\/#website"},"datePublished":"2017-01-27T00:01:21+00:00","dateModified":"2025-01-27T18:21:50+00:00","description":"Nous fournissons une approbation officielle aux groupes d\u2019int\u00e9r\u00eat sp\u00e9ciaux (GIS), afin de promouvoir la collaboration entre scientifiques et professionnels de la sant\u00e9 issus de diverses disciplines qui partagent des int\u00e9r\u00eats sp\u00e9cialis\u00e9s communs dans le domaine de l\u2019h\u00e9patologie.","breadcrumb":{"@id":"https:\/\/hepatology.ca\/research\/special-interest-groups\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hepatology.ca\/research\/special-interest-groups\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/hepatology.ca\/research\/special-interest-groups\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hepatology.ca\/"},{"@type":"ListItem","position":2,"name":"Research","item":"https:\/\/hepatology.ca\/fr\/research\/"},{"@type":"ListItem","position":3,"name":"Special Interest Groups"}]},{"@type":"WebSite","@id":"https:\/\/hepatology.ca\/#website","url":"https:\/\/hepatology.ca\/","name":"LCAP","description":"Le foyer canadien des experts du foie","publisher":{"@id":"https:\/\/hepatology.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hepatology.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/hepatology.ca\/#organization","name":"Association canadienne pour l&#039;\u00e9tude du foie","url":"https:\/\/hepatology.ca\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/hepatology.ca\/#\/schema\/logo\/image\/","url":"https:\/\/hepatology.ca\/wp-content\/uploads\/2024\/06\/CASL-logo-transparent-background.png","contentUrl":"https:\/\/hepatology.ca\/wp-content\/uploads\/2024\/06\/CASL-logo-transparent-background.png","width":1040,"height":294,"caption":"Canadian Association for the Study of the Liver"},"image":{"@id":"https:\/\/hepatology.ca\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/hepatology.ca\/fr\/wp-json\/wp\/v2\/pages\/1339","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hepatology.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/hepatology.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/hepatology.ca\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/hepatology.ca\/fr\/wp-json\/wp\/v2\/comments?post=1339"}],"version-history":[{"count":24,"href":"https:\/\/hepatology.ca\/fr\/wp-json\/wp\/v2\/pages\/1339\/revisions"}],"predecessor-version":[{"id":4673,"href":"https:\/\/hepatology.ca\/fr\/wp-json\/wp\/v2\/pages\/1339\/revisions\/4673"}],"up":[{"embeddable":true,"href":"https:\/\/hepatology.ca\/fr\/wp-json\/wp\/v2\/pages\/932"}],"wp:attachment":[{"href":"https:\/\/hepatology.ca\/fr\/wp-json\/wp\/v2\/media?parent=1339"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}